FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:327-331 August 3, 2000 Number 5 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background and Methods We tested the usefulness of measuring the hepatic iron concentration to evaluate total body iron stores in patients who had been cured of thalassemia major by bone marrow transplantation and who were undergoing phlebotomy treatment to remove excess iron.

Results We began treatment with phlebotomy a mean (±SD) of 4.3±2.7 years after transplantation in 48 patients without hepatic cirrhosis. In the group of 25 patients with liver-biopsy samples that were at least 1.0 mg in dry weight, there was a significant correlation between the decrease in the hepatic iron concentration and total body iron stores (r=0.98, P<0.001). Assuming that the hepatic iron concentration is reduced to zero with complete removal of body iron stores during phlebotomy, the amount of total body iron stores (in milligrams per kilogram of body weight) is equivalent to 10.6 times the hepatic iron concentration (in milligrams per gram of liver, dry weight). With the use of this equation, we could reliably estimate total body iron stores as high as 250 mg per kilogram of body weight, with a standard error of less than 7.9.

Conclusions The hepatic iron concentration is a reliable indicator of total body iron stores in patients with thalassemia major. In patients with transfusion-related iron overload, repeated determinations of the hepatic iron concentration can provide a quantitative means of measuring the long-term iron balance.

Source Information

From the Unità Operativa di Ematologia e Centro Trapianto Midollo Osseo di Muraglia, Azienda Ospedale di Pesaro, Pesaro, Italy (E.A., M.R., D.B., C.G., M.G., P.P., G.L.); the Departments of Pediatrics and Medicine, Columbia University College of Physicians and Surgeons, New York (G.M.B.); and the Division of Epidemiology, Department of Medicine, University of California, Irvine, Calif. (C.E.M.).

Address reprint requests to Dr. Angelucci at Unità Operativa di Ematologia di Muraglia, Azienda Ospedale di Pesaro, 61100 Pesaro, Italy, or at emnang{at}tin.it.

Full Text of this Article

Related Letters:

Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major
Bonkovsky H. L., Davidoff A., Stark D. D., Kami M., Hamaki T., Kishi Y., Angelucci E., Brittenham G. M., Lucarelli G.
Extract | Full Text  
N Engl J Med 2000; 343:1656-1657, Nov 30, 2000. Correspondence

This article has been cited by other articles:

• Adamkiewicz, T. V., Abboud, M. R., Paley, C., Olivieri, N., Kirby-Allen, M., Vichinsky, E., Casella, J. F., Alvarez, O. A., Barredo, J. C., Lee, M. T., Iyer, R. V., Kutlar, A., McKie, K. M., McKie, V., Odo, N., Gee, B., Kwiatkowski, J. L., Woods, G. M., Coates, T., Wang, W., Adams, R. J. (2009). Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood 114: 4632-4638 [Abstract] [Full Text]  
• Noetzli, L. J., Papudesi, J., Coates, T. D., Wood, J. C. (2009). Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 114: 4021-4026 [Abstract] [Full Text]  
• Andreani, M., Radio, F. C., Testi, M., De Bernardo, C., Troiano, M., Majore, S., Bertucci, P., Polchi, P., Rosati, R., Grammatico, P. (2009). Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major. haematol 94: 1293-1296 [Abstract] [Full Text]  
• Angelucci, E., Barosi, G., Marchetti, M., Tura, S. (2009). Italian Society of Hematology guidelines for thalassemia and non-invasive iron measurements: author reply. haematol 94: 295-296 [Full Text]  
• Noetzli, L. J., Carson, S. M., Nord, A. S., Coates, T. D., Wood, J. C. (2008). Longitudinal analysis of heart and liver iron in thalassemia major. Blood 112: 2973-2978 [Abstract] [Full Text]  
• Harmatz, P., Jonas, M. M., Kwiatkowski, J. L., Wright, E. C., Fischer, R., Vichinsky, E., Giardina, P. J., Neufeld, E. J., Porter, J., Olivieri, N., for the Thalassemia Clinical Research Network, (2008). Safety and efficacy of pegylated interferon {alpha}-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia. haematol 93: 1247-1251 [Abstract] [Full Text]  
• Wood, J. C., Origa, R., Agus, A., Matta, G., Coates, T. D., Galanello, R. (2008). Onset of cardiac iron loading in pediatric patients with thalassemia major. haematol 93: 917-920 [Abstract] [Full Text]  
• Vichinsky, E. (2008). Oral Iron Chelators and the Treatment of Iron Overload in Pediatric Patients With Chronic Anemia. Pediatrics 121: 1253-1256 [Full Text]  
• Angelucci, E., Barosi, G., Camaschella, C., Cappellini, M. D., Cazzola, M., Galanello, R., Marchetti, M., Piga, A., Tura, S. (2008). Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. haematol 93: 741-752 [Abstract] [Full Text]  
• Cohen, A. R., Glimm, E., Porter, J. B. (2008). Effect of transfusional iron intake on response to chelation therapy in -thalassemia major. Blood 111: 583-587 [Abstract] [Full Text]  
• Cazzola, M., Della Porta, M. G., Malcovati, L. (2008). Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes. ASH Education Book 2008: 166-175 [Abstract] [Full Text]  
• Aydinok, Y., Ulger, Z., Nart, D., Terzi, A., Cetiner, N., Ellis, G., Zimmermann, A., Manz, C. (2007). A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major. haematol 92: 1599-1606 [Abstract] [Full Text]  
• Cappellini, M. D., Cohen, A., Piga, A., Bejaoui, M., Perrotta, S., Agaoglu, L., Aydinok, Y., Kattamis, A., Kilinc, Y., Porter, J., Capra, M., Galanello, R., Fattoum, S., Drelichman, G., Magnano, C., Verissimo, M., Athanassiou-Metaxa, M., Giardina, P., Kourakli-Symeonidis, A., Janka-Schaub, G., Coates, T., Vermylen, C., Olivieri, N., Thuret, I., Opitz, H., Ressayre-Djaffer, C., Marks, P., Alberti, D. (2006). A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood 107: 3455-3462 [Abstract] [Full Text]  
• Iolascon, A., d'Apolito, M., Servedio, V., Cimmino, F., Piga, A., Camaschella, C. (2006). Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 107: 349-354 [Abstract] [Full Text]  
• St. Pierre, T. G., Jeffrey, G. P., Rossi, E., Fleming, A. J., Chua-anusorn, W., Clark, P. R., Olynyk, J. K. (2005). A New Model for Predicting Venesection Therapy Requirements in Hereditary Hemochromatosis Using Non-Invasive Liver Iron Concentration Measurement.. ASH ANNUAL MEETING ABSTRACTS 106: 3596-3596 [Abstract]  
• Wood, J. C., Enriquez, C., Ghugre, N., Tyzka, J. M., Carson, S., Nelson, M. D., Coates, T. D. (2005). MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106: 1460-1465 [Abstract] [Full Text]  
• Wang, Z. J., Lian, L., Chen, Q., Zhao, H., Asakura, T., Cohen, A. R. (2005). 1/T2 and Magnetic Susceptibility Measurements in a Gerbil Cardiac Iron Overload Model. Radiology 234: 749-755 [Abstract] [Full Text]  
• Porter, J. B. (2005). Liver iron measurement by MRI. Blood 105: 437-438 [Full Text]  
• St. Pierre, T. G., Clark, P. R., Chua-anusorn, W., Fleming, A. J., Jeffrey, G. P., Olynyk, J. K., Pootrakul, P., Robins, E., Lindeman, R. (2005). Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105: 855-861 [Abstract] [Full Text]  
• Khong, P.-L., Chan, G. C. F., Lee, S.-L., Au, W. Y., Fong, D. Y. T., Tsang, K. W. T., Ooi, G.-C. (2003). {beta}-Thalassemia Major: Thin-Section CT Features and Correlation with Pulmonary Function and Iron Overload. Radiology 229: 507-512 [Abstract] [Full Text]  
• Gehrke, S. G., Kulaksiz, H., Herrmann, T., Riedel, H.-D., Bents, K., Veltkamp, C., Stremmel, W. (2003). Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 102: 371-376 [Abstract] [Full Text]  
• Brittenham, G. M., Badman, D. G. (2003). Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101: 15-19 [Abstract] [Full Text]  
• Cheung, Y.F., Chan, G. C.F., Ha, S.Y. (2002). Arterial Stiffness and Endothelial Function in Patients With {beta}-Thalassemia Major. Circulation 106: 2561-2566 [Abstract] [Full Text]  
• Li, A M, Chan, D, Li, C K, Wong, E, Chan, Y L, Fok, T F (2002). Respiratory function in patients with thalassaemia major: relation with iron overload. Arch. Dis. Child. 87: 328-330 [Abstract] [Full Text]  
• Angelucci, E., Muretto, P., Nicolucci, A., Baronciani, D., Erer, B., Gaziev, J., Ripalti, M., Sodani, P., Tomassoni, S., Visani, G., Lucarelli, G. (2002). Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 100: 17-21 [Abstract] [Full Text]  
• Muretto, P., Angelucci, E., Lucarelli, G. (2002). Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation. ANN INTERN MED 136: 667-672 [Abstract] [Full Text]  
• Li, C K, Chik, K W, Lam, C W K, To, K F, Yu, S C H, Lee, V, Shing, M M K, Cheung, A Y K, Yuen, P M P (2002). Liver disease in transfusion dependent thalassaemia major. Arch. Dis. Child. 86: 344-347 [Abstract] [Full Text]  
• Kushner, J. P., Porter, J. P., Olivieri, N. F. (2001). Secondary Iron Overload. ASH Education Book 2001: 47-61 [Abstract] [Full Text]  
• Bonkovsky, H. L., Davidoff, A., Stark, D. D., Kami, M., Hamaki, T., Kishi, Y., Angelucci, E., Brittenham, G. M., Lucarelli, G. (2000). Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major. NEJM 343: 1656-1657 [Full Text]